Changes in trough levels of whole blood cyclosporine and graft function of a kidney transplant recipient with onset of hypothyroidism after transplantation

Transplantation

Volumn 62, Issue 10, 1996, Pages 1509-1511

  Nishimura, Motonobu ^a   Yamada, Kenichi ^a   Matsushita, Kazuyuki ^a   Sakamoto, Kaoru ^a   Saisu, Takashi ^a   Kashiwabara, Hidehiko ^a   Yokoyama, Takeo ^a  

^a SAKURA NATIONAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CYCLOSPORIN; CYTOCHROME P450; LIPOPROTEIN; THYROID HORMONE;

ADULT; ARTICLE; CASE REPORT; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; ENZYME ACTIVITY; GRAFT SURVIVAL; HUMAN; HYPOTHYROIDISM; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL;

EID: 0029807682     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199611270-00022     Document Type: Article

References (10)

1. Lindholm A. Factors influencing the pharmacokinetics of cyclosporine in man. Ther Drug Monit 1991; 13: 465.
2. Kahan B. Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters. Transplantation 1985; 40: 457.
3. Yee GC. Pharmacokinetic interactions between cyclosporine and other drugs. Transplant Proc 1990; 22: 1203.
4. Ram PA, Waxman DJ. Thyroid hormone stimulation of NADPH P450 reductase expression in hepatic and extrahepatic tissues. J Biol Chem 1992; 267: 3294.
5. Leong SO, Lye WC, Tan CC, Lee EJ. Acute cyclosporine A nephrotoxicity in a renal allograft recipient with hypothyroidism. Am J Kidney Dis 1995; 25: 503.
6. Awni WM, Heim-Duthoy K, Kasiske BL. Impact of lipoproteins on cyclosporine pharmacokinetics and biological activity in transplant patients, Transplant Proc 1990; 22: 1993.
7. Luke DR. Immunosuppressive effect of cyclosporine in the hyperlipidemic rat model. Biopharm Drug Dispos 1992; 13: 635.
8. de Greon PC, Aksamit AJ, Rakela J, Forbes GS, Krom RAF. Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol. N Engl J Med 1987; 317: 861.
9. Rödl S, Jürgens G, Fuchs G, Khoschsorr G. Role of human serum lipoproteins on the immunosuppressive action of cyclosporine on PHA-stimulated human peripheral blood mononuclear cells. Biblthca Cardiol 1988; 43: 57.
10. Chait A, Bierman EL, Albers JJ. Regulatory role of triiodothyronine in the degradation of low density lipoprotein by cultured human skin fibroblasts. J Clin Endocrinol Metab 1979; 48: 887.